Hypomorphic GINS3 variants alter DNA replication and cause Meier-Gorlin syndrome.


Journal

JCI insight
ISSN: 2379-3708
Titre abrégé: JCI Insight
Pays: United States
ID NLM: 101676073

Informations de publication

Date de publication:
23 05 2022
Historique:
received: 22 10 2021
accepted: 12 04 2022
entrez: 23 5 2022
pubmed: 24 5 2022
medline: 25 5 2022
Statut: epublish

Résumé

The eukaryotic CDC45/MCM2-7/GINS (CMG) helicase unwinds the DNA double helix during DNA replication. The GINS subcomplex is required for helicase activity and is, therefore, essential for DNA replication and cell viability. Here, we report the identification of 7 individuals from 5 unrelated families presenting with a Meier-Gorlin syndrome-like (MGS-like) phenotype associated with hypomorphic variants of GINS3, a gene not previously associated with this syndrome. We found that MGS-associated GINS3 variants affecting aspartic acid 24 (D24) compromised cell proliferation and caused accumulation of cells in S phase. These variants shortened the protein half-life, altered key protein interactions at the replisome, and negatively influenced DNA replication fork progression. Yeast expressing MGS-associated variants of PSF3 (the yeast GINS3 ortholog) also displayed impaired growth, S phase progression defects, and decreased Psf3 protein stability. We further showed that mouse embryos homozygous for a D24 variant presented intrauterine growth retardation and did not survive to birth, and that fibroblasts derived from these embryos displayed accelerated cellular senescence. Taken together, our findings implicate GINS3 in the pathogenesis of MGS and support the notion that hypomorphic variants identified in this gene impaired cell and organismal growth by compromising DNA replication.

Identifiants

pubmed: 35603789
pii: 155648
doi: 10.1172/jci.insight.155648
pmc: PMC9215265
doi:
pii:

Substances chimiques

Chromosomal Proteins, Non-Histone 0
GINS3 protein, human 0
Minichromosome Maintenance Proteins EC 3.6.4.12

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Eur J Hum Genet. 2017 May;25(5):646-650
pubmed: 28198391
BMC Pediatr. 2013 Apr 20;13:59
pubmed: 23601190
World Health Organ Tech Rep Ser. 1995;854:1-452
pubmed: 8594834
Nature. 2014 Nov 20;515(7527):355-64
pubmed: 25409824
Nature. 2020 Jul;583(7818):699-710
pubmed: 32728249
Science. 1991 Mar 15;251(4999):1351-5
pubmed: 1900642
Nat Methods. 2010 Apr;7(4):248-9
pubmed: 20354512
Ann Anat. 2021 May;235:151704
pubmed: 33600952
Nat Struct Mol Biol. 2011 Apr;18(4):471-7
pubmed: 21378962
Cold Spring Harb Protoc. 2016 Feb 01;2016(2):pdb.prot085118
pubmed: 26832684
Nat Protoc. 2016 Jan;11(1):1-9
pubmed: 26633127
Proc Natl Acad Sci U S A. 2017 Jan 31;114(5):E697-E706
pubmed: 28096349
J Clin Invest. 2012 Mar;122(3):814-20
pubmed: 22354170
Genet Med. 2020 Feb;22(2):326-335
pubmed: 31474763
Nat Cell Biol. 2006 Apr;8(4):358-66
pubmed: 16531994
J Allergy Clin Immunol. 2003 Nov;112(5):973-80
pubmed: 14610491
PLoS Genet. 2021 Nov 15;17(11):e1009909
pubmed: 34780483
Nucleic Acids Res. 2009 Jul;37(Web Server issue):W593-9
pubmed: 19465395
Nucleic Acids Res. 2016 Apr 7;44(6):2706-26
pubmed: 26748095
Methods Mol Biol. 2009;521:673-87
pubmed: 19563133
Curr Biol. 2013 Apr 8;23(7):543-52
pubmed: 23499531
Nature. 2014 Jun 12;510(7504):293-297
pubmed: 24805245
J Pediatr. 2019 Dec;215:192-198
pubmed: 31630891
Eur J Med Genet. 2021 Apr;64(4):104182
pubmed: 33639314
Nat Protoc. 2015 Sep;10(9):1297-307
pubmed: 26226461
J Cell Biol. 2013 Apr 29;201(3):373-83
pubmed: 23629964
Nucleic Acids Res. 2020 Jul 9;48(12):6980-6995
pubmed: 32453425
Genome Biol. 2014;15(12):550
pubmed: 25516281
Nature. 2020 May;581(7809):434-443
pubmed: 32461654
Cell. 2013 Nov 21;155(5):1088-103
pubmed: 24267891
EMBO J. 2009 Oct 7;28(19):2992-3004
pubmed: 19661920
Proc Natl Acad Sci U S A. 2006 Jul 5;103(27):10236-10241
pubmed: 16798881
Pediatrics. 2005 Sep;116(3):e445-9
pubmed: 16061569
Mol Microbiol. 2014 May;92(4):659-80
pubmed: 24628792
Genes Dev. 2003 May 1;17(9):1153-65
pubmed: 12730134
FEBS J. 2021 Jan;288(1):56-80
pubmed: 32961620
Am Fam Physician. 1998 Oct 15;58(6):1384-90, 1393-4
pubmed: 9803202
Cell. 2011 Sep 16;146(6):931-41
pubmed: 21925316
Nat Genet. 2013 Jun;45(6):580-5
pubmed: 23715323
Am J Hum Genet. 2016 Jul 7;99(1):125-38
pubmed: 27374770
Eur J Med Genet. 2020 Feb;63(2):103652
pubmed: 30986546
Nucleic Acids Res. 2021 Jan 8;49(D1):D677-D686
pubmed: 33095861
Nature. 2016 Sep 22;537(7621):508-514
pubmed: 27626380
J Clin Invest. 2017 May 1;127(5):1991-2006
pubmed: 28414293
Eur J Hum Genet. 2021 Jul;29(7):1110-1120
pubmed: 33654309
Nat Genet. 2011 Feb 27;43(4):356-9
pubmed: 21358632
Proc Natl Acad Sci U S A. 2013 Dec 3;110(49):19760-5
pubmed: 24255107
J Med Genet. 2020 Mar;57(3):195-202
pubmed: 31784481
Proc Natl Acad Sci U S A. 2014 Dec 2;111(48):17224-9
pubmed: 25413365
Nucleic Acids Res. 2019 Jan 8;47(D1):D886-D894
pubmed: 30371827
Proc Natl Acad Sci U S A. 2014 Oct 28;111(43):15390-5
pubmed: 25313033
Am J Hum Genet. 2015 Dec 3;97(6):904-13
pubmed: 26637980
Cell Rep. 2019 May 7;27(6):1886-1896.e6
pubmed: 31067471
DNA Repair (Amst). 2015 May;29:23-35
pubmed: 25758782
J Med Genet. 2021 Aug 5;:
pubmed: 34353863
J Cell Biol. 2012 Mar 19;196(6):801-10
pubmed: 22412018
Nat Commun. 2018 Nov 29;9(1):5061
pubmed: 30498216
Blood. 2012 Mar 22;119(12):2754-63
pubmed: 22294731
Biochem Soc Trans. 2020 Jun 30;48(3):1057-1066
pubmed: 32369549
Front Cell Dev Biol. 2020 Jul 31;8:701
pubmed: 32850821
Nat Protoc. 2006;1(5):2365-76
pubmed: 17406480
Mol Cell. 2010 Jan 29;37(2):247-58
pubmed: 20122406
J Biol Chem. 2011 Aug 19;286(33):28963-28977
pubmed: 21705323
Nat Methods. 2011 Jan;8(1):70-3
pubmed: 21131968
Orphanet J Rare Dis. 2015 Sep 17;10:114
pubmed: 26381604
J Clin Invest. 2012 Mar;122(3):821-32
pubmed: 22354167
Mol Cell. 2006 Feb 17;21(4):581-7
pubmed: 16483939
J Clin Invest. 2014 Sep;124(9):4028-38
pubmed: 25105364
Eur J Hum Genet. 2012 Jun;20(6):598-606
pubmed: 22333897

Auteurs

Mary E McQuaid (ME)

Maisonneuve-Rosemont Hospital Research Center, Montreal, Quebec, Canada.

Kashif Ahmed (K)

Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto, Ontario, Canada.

Stephanie Tran (S)

Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto, Ontario, Canada.
Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.

Justine Rousseau (J)

CHU Sainte-Justine, Montreal, Quebec, Canada.

Ranad Shaheen (R)

Department of Translational Genomics, Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.

Kristin D Kernohan (KD)

CHEO Research Institute, Ottawa, Ontario, Canada.
Newborn Screening Ontario, CHEO, Ottawa, Ontario, Canada.

Kyoko E Yuki (KE)

Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto, Ontario, Canada.

Prerna Grover (P)

Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto, Ontario, Canada.

Ema S Dreseris (ES)

Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto, Ontario, Canada.

Sameen Ahmed (S)

Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto, Ontario, Canada.
Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.

Lucie Dupuis (L)

Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto, Ontario, Canada.

Jennifer Stimec (J)

Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto, Ontario, Canada.

Mary Shago (M)

Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto, Ontario, Canada.

Zuhair N Al-Hassnan (ZN)

Department of Translational Genomics, Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.

Roch Tremblay (R)

Maisonneuve-Rosemont Hospital Research Center, Montreal, Quebec, Canada.

Philipp G Maass (PG)

Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto, Ontario, Canada.
Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.

Michael D Wilson (MD)

Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto, Ontario, Canada.
Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.

Eyal Grunebaum (E)

Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto, Ontario, Canada.

Kym M Boycott (KM)

CHEO Research Institute, Ottawa, Ontario, Canada.

François-Michel Boisvert (FM)

University of Sherbrooke, Sherbrooke, Quebec, Canada.

Sateesh Maddirevula (S)

Department of Translational Genomics, Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.

Eissa A Faqeih (EA)

Section of Medical Genetics, Children's Specialist Hospital, and.

Fahad Almanjomi (F)

Department of Pediatric Hematology and Oncology, Comprehensive Cancer Center, King Fahad Medical City, Riyadh, Saudi Arabia.

Zaheer Ullah Khan (ZU)

Department of Pediatric Hematology and Oncology, Comprehensive Cancer Center, King Fahad Medical City, Riyadh, Saudi Arabia.

Fowzan S Alkuraya (FS)

Department of Translational Genomics, Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Department of Anatomy and Cell Biology, College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.

Philippe M Campeau (PM)

CHU Sainte-Justine, Montreal, Quebec, Canada.

Peter Kannu (P)

Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto, Ontario, Canada.
Department of Medical Genetics, University of Alberta, Edmonton, Alberta, Canada.

Eric I Campos (EI)

Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto, Ontario, Canada.
Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.

Hugo Wurtele (H)

Maisonneuve-Rosemont Hospital Research Center, Montreal, Quebec, Canada.
Department of Medicine, University of Montreal, Montreal, Quebec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH